ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Wickman, Allie

Follow Wickman, Allie: Website |


Fiscal cliff advice from Kynikos’ Chanos: Let’s attack healthcare costs

Fiscal cliff advice from Kynikos’ Chanos: Let’s attack healthcare costs

November 29, 2012 9:58 am by | 0 Comments

Bloomberg Television's Trish Regan sat down with four of the nation's brightest business minds to discuss their solutions for avoiding the fiscal cliff on Wednesday. The panelists were former Treasury ... Read more

Pfizer: Study shows Toviaz reduces UUI in patients with OAB after poor response to Detrol LA

Pfizer: Study shows Toviaz reduces UUI in patients with OAB after poor response to Detrol LA

August 3, 2012 8:03 am by | 0 Comments

Pfizer Inc. (NYSE: PFE) announced today that a Phase 4 study assessing the efficacy and safety of Toviaz(R) (fesoterodine fumarate) in patients with overactive bladder (OAB) met its primary endpoint. ... Read more


Rosetta Genomics pricing public offering of 5.5 million ordinary shares at $5/share

Rosetta Genomics pricing public offering of 5.5 million ordinary shares at $5/share

August 3, 2012 6:46 am by | 0 Comments

Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG) today announced the pricing of an underwritten public offering of 5,500,000 ordinary shares at a public offering price of $5.00 per share. ... Read more

ZIOPHARM Oncology granted new U.S. patent for palifosfamide

ZIOPHARM Oncology granted new U.S. patent for palifosfamide

August 2, 2012 6:50 am by | 0 Comments

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the United States Patent and Trademark Office issued Patent No. 8,232,262 entitled "Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents" ... Read more

Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with Acquisition of PHASEIN

Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with Acquisition of PHASEIN

August 1, 2012 4:14 pm by | 0 Comments

Masimo (NASDAQ: MASI), the inventor of rainbow Pulse CO-Oximetry, and SET Measure-Through Motion and Low Perfusion pulse oximetry, today announced it has acquired PHASEIN AB (Stockholm, Sweden), a developer and ... Read more

LTC Announces Acquisition of Two Skilled Nursing Facilities for $54M

LTC Announces Acquisition of Two Skilled Nursing Facilities for $54M

August 1, 2012 9:30 am by | 0 Comments

LTC Properties, Inc. (NYSE: LTC) announced today that it acquired two skilled nursing facilities with a total of 288 licensed beds for $54.0 million. One property located in Cincinnati, Ohio ... Read more

Cell Cure Neurosciences awarded $1.33M grant from Israel’s Office of the Chief Scientist

Cell Cure Neurosciences awarded $1.33M grant from Israel’s Office of the Chief Scientist

August 1, 2012 8:46 am by | 0 Comments

BioTime, Inc. (NYSE: BTX) and its subsidiary Cell Cure Neurosciences Ltd. today announced that Cell Cure has been awarded a grant for 2012 of 5.04 million Shekels (approximately $1.33 million) ... Read more


Pharmacyclics Triggers Significant Milestone Payment, Provides Clinical Update

Pharmacyclics Triggers Significant Milestone Payment, Provides Clinical Update

August 1, 2012 6:38 am by | 0 Comments

Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international Phase III randomized, multicenter, open-label clinical trial, RESONATE (PCYC-1112), of ibrutinib versus ofatumumab for patients with relapsed or refractory chronic lymphocytic... ... Read more